Publications
- Complete remission of metastatic malignant melanoma treated with nivolumab, complicated with pulmonary toxicity2018 | Faculty of Medicine in Hradec Králové
- Pembrolizumab in pretreated patient2018 | Faculty of Medicine in Hradec Králové
- Current possibilities of immunotherapy in the treatment of malignant melanoma2018 | Faculty of Medicine in Hradec Králové
- Assessment of Incidence and Character of Neurologic/Neuropsychiatric Complications in a Group of Patients with Malignant Melanoma Treated with Adjuvant High Dose interferon2018 | Central Library of Charles University
- Non-specific immunotherapy inhibits angiogenesis - results of the monitoring of serum levels of vascular endothelial growth factor and matrix metalloproteinase 8 in patients with malignant melanoma receiving adjuvant high-dose interferon therapy2017 | First Faculty of Medicine, Central Library of Charles University
- Immunoterapy related toxicities2017 | Faculty of Medicine in Hradec Králové
- Dual targeted therapy in patients with malignant melanoma2017 | Faculty of Medicine in Hradec Králové
- The Role of BRAF/MEK Inhibition in Metastatic Malignant Melanoma - a Case Study2016 | Faculty of Medicine in Hradec Králové
- Cancer Immunology2015 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Possible Pitfalls of Ipilimumab Therapy in Malignant Melanoma - a Case Report2015 | Faculty of Medicine in Hradec Králové
Loading network view...